NCT01783197 2023-08-04
Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Canadian Cancer Trials Group
Phase 1 Completed
Canadian Cancer Trials Group
NSABP Foundation Inc
Cancer Research and Biostatistics Clinical Trials Consortium
Children's Oncology Group